Valeant Pharmaceuticals International, Inc. 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Nov 8, 2013
Insider Transaction Report
Form 4
Farmer Ronald Harold
Director
Transactions
- Purchase
Common Stock, no par value
2013-11-06$107.98/sh+1,500$161,970→ 27,808 total
Footnotes (2)
- [F1]This number represents the weighted average purchase price for all purchases of common stock purchased by the reporting officer. Actual purchases were in the range of $107.34 and $108.30. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each price.
- [F2]This number represents common shares purchased by the director, as well as other outstanding equity awards that were previously reported in Table 1.